In Management of Moderate to Severe Infections
Faropenem Sodium Extended Release Tablets
New, Active and FULL of Action
Faropenem: An Oral Prodrug
  • Active against the major respiratory pathogens, including penicillin- resistant S. pneumoniae and M. catarrhalis
  • Faropenemem is four fold more active than amoxicillin clavulanate) eight fold more active than cefdinir and cefuroxime
  • Against penicillin resistant S. pneumoniae its activity is equivalent to that of telithromycin and levofloxacin & more active than all other B-lactam tested. including amoxicillin-clavulanate. cefdinir and cefuroxime
TRUSTED More and More by INDIAN Doctors
  • Offers improved chemical stability and reduced CNS effects. compared with imipenem
  • Demonstrates broad-spectrum in vitro antimicrobial activity against many Gram-positive and -negative aerobes and anaerobes
  • Resistant to hydrolysis by nearly all beta-lactamases, including Lextended-spectrum beta-lactamases and AmpC beta-lactamases
Prescribe In
  • Acute Bacterial Sinusitis
  • Community Acquired Pneumonia
  • Urinary Tract Infections
  • Acute Exacerbations of Chronic Bronchitis
  • Severe Bacterial Infections
  • Uncomplicated Skin & Skin Structure Infections